banner.jpgbanner.jpg

GemPharmatech

Advancing Science. Empowering Discovery

We are a Contract Research Organization (CRO) dedicated to advancing the next generation of scientific breakthroughs. We partner with biotechs, academic institutions, and pharmaceutical companies to provide expert research services that accelerate discovery and bring innovative therapies closer to reality.
  • 30,000+
    Total strains
  • 8,000+
    Annual Model Creation Capability
  • 6,100+
    SCI Articles Published
  • 60,000+
    Impact Factor
  • 2,000+
    Studies Completed Annually
  • 300+
    IND-Enabling Studies
  • Our Expertise

    Science You Can Rely On

    Our team of experienced scientists and researchers brings deep expertise across a broad range of disciplines, delivering high-quality, reliable results tailored to the unique needs of each client. Whether you’re in early-stage research or preclinical development, we work as an extension of your team — combining scientific rigor with a collaborative, flexible approach.

    about1-img1.jpg
  • Company Overview

    Leading The Way In Preclinical Research

    Founded in 2017, GemPharmatech has rapidly grown to become Asia’s largest provider of laboratory mouse models. Our state-of-the-art facilities and dedicated team of scientists support pharmaceutical companies, biotechnology firms, and academic institutions worldwide.

    https://www.gempharmatech.comabout1-ico1.svg

    Headquarters: Nanjing, China

    https://www.gempharmatech.comabout1-ico2.svg

    Global Operations

    about1-img2.jpg
about2-img.jpg
Model Collection

Precision Models For Every Research Need

GemPharmatech is a world leader in gene editing and model creation, offering a library of over 30,000 models — including KO/cKO, humanized, immunodeficient, and germ-free mice. With decades of combined expertise using advanced gene editing technologies, our scientists deliver precise, validated models tailored to your exact research needs.

about2-ico1.svg

KO/cKO

Knockout Models

about2-ico2.svg

Humanized

Humanized Models

about2-ico3.svg

Immunodeficient

NCG & Variants

about2-ico4.svg

Germ-Free

Axenic Models

Development History

Our Journey

  • 2002
  • 2017
  • 2018
  • 2019
  • 2020
  • 2021
  • 2022
  • 2023
  • 2024
  • 2025

2002 :

Co-founded the Model Animal Research Center (MARC) and National Resource Center for Mutant Mice (NRCMM).

2017 :

Established GemPharmatech Co., Ltd. with headquarters in Nanjing, China.

2018 :

Established Guangdong, Chengdu, and Changzhou subsidiaries.
Initiated the Knockout All Project (KOAP) to create KO/cKO mice for all protein coding regions in the mouse genome.

2019 :

Secured Series A Funding (160 million RMB).
Launched the humanized mouse strain project and the NCG-derived strain platform.
Achieved AAALAC International accreditation.

2020 :

Established US (GemPharmatech LLC) and Beijing subsidiaries.
Secured Series B Funding (400 million RMB).
Obtained the SPF-grade Laboratory Animal Production License.

2021 :

Established Shanghai subsidiary.
Launched the Drug Screening Mouse Program (DSMP).
Achieved ISO 9001 QMS certification.

2022 :

Listed on the Shaghai Stock Exchange STAR Market (Stock Code: 688046).
Expanded business coverage to 20+ countries.
Launched “The Wild Mouse Project"

2023 :

Established production bases in Beijing and Shanghai.
Received US OLAW assurance.

2024 :

Opened Guangdong Industrial Park.
Founded NeoMab® Biotechnology (Suzhou).
Launched the NeoMab® fully human antibody mouse platform.

2025 :

Opened first overseas operation site in San Diego, CA.
Established subsidiaries in South Korea and Hong Kong.
Global workforce surpassed 1,700+ employees.
backgroundImg

Leadership

Our Leadership Team

高翔.png
comma
Everything we do is to provide scientists with the tools they need to advance their research. This was true when I founded GemPharmatech, when we started our knockout model collection, and true in how we move our own research and development forward.
Dr. Gao Xiang, PHD
Founder and Chairman
index-box4-img2.png
comma
We are dedicated to providing our global clients with the expertise, in vivo pharmacology solutions, and premier mouse models needed to accelerate therapeutic development and improve patient lives worldwide.
Brandy Wilkinson, PHD
CEO, North America
arrow-right-garrow-right-w
arrow-right-garrow-right-w
Regional Office

You Can Find Us Here

North American Headquarters

Nanjing, China

Changzhou, China

Chengdu, China

Changzhou, China

Shanghai, China

Beijing, China

North American Headquarters

Located in the heart of San Diego’s Sorrento Valley biotech hub, this 13,000 sq. ft. facility features a high-spec vivarium, wet laboratory space, ABSL-1 and ABSL-2 capabilities, and capacity for more than 4,000 cages, supporting custom breeding, preclinical efficacy studies, and humanized model services. This site provides access to more than 25,000 mouse models, including genetically engineered mouse models (GEMMs), immunodeficient mice, next-generation NCG variants, and humanized mouse models.

North American Headquarters

Nanjing, China

As the company headquarters, the facility spans 9,568 m², including 5,657 m² of SPF barrier space and a cage capacity exceeding 73,000. It holds SPF-grade and germ-free-grade Laboratory Animal Production and Use Licenses, operates under AAALAC standards, and has obtained OLAW, ISO9001, ISO14001, and ISO45001 certifications.

Nanjing, China

Changzhou, China

This facility serves as a shared resource platform for genetically engineered mouse models, supporting biomedical research and clinical translation. It comprises 10,892.6 m² of total space, including 7,954 m² of SPF barrier area with a cage capacity exceeding 57,680. The facility holds the Laboratory Animal Production and Use License, operates under AAALAC international standards, and maintains CNAS accreditation for its mouse testing laboratory.

Changzhou, China

Chengdu, China

The total area is 12,000 m², including 6,976 m² of SPF barrier space and a cage capacity exceeding 60,000. It holds the Laboratory Animal Production and Use License.

Chengdu, China

Changzhou, China

This facility is dedicated to the production and application of laboratory animal models for life science and health research. Its total area is 4,150 m², with 1,560 m² of SPF barrier space and a cage capacity exceeding 37,000. The facility holds the Laboratory Animal Production License and operates under AAALAC international standards.

Changzhou, China

Shanghai, China

This facility specializes in multi-dimensional humanized mouse models—encompassing gene, cell, tissue, and microbiota—for preclinical evaluation of biologics, cell therapies, and gene therapies, offering one-stop solutions for drug discovery. The total area is 4,013 m², with 2,127.8 m² of SPF barrier space and a cage capacity of over 24,000. It has obtained the Laboratory Animal Use License and operates under AAALAC accreditation.

Shanghai, China

Beijing, China

This facility focuses on disease mechanism studies, drug screening platforms, and microbiota humanized mouse models. It occupies 6,500 m², with 2,240 m² of SPF barrier space and a cage capacity exceeding 35,000. The facility holds the Laboratory Animal Production and Use License and has obtained CNAS laboratory animal institution accreditation.

Beijing, China

background-image

Contact Information

Get in touch with our team

  • about8-ico1.svg

    Phone

    400-9660-890

  • about8-ico2.svg

    Email

    info@gempharmatech.com

  • about8-ico3.svg

    Address

    Nanjing,Jiangsu,China

Submit Inquiry

First Name*

Last Name*

Organization*

Email*

Country/Region*

Select Country/Region

State/Province*

City

Area of interest*

Select Area of Interest

Research Focus

Additional Info

Submitarrowarrow

Contact Us

First Name*

Last Name*

Organization*

Email*

Country/Region*

Select Country/Region

State/Province*

City

Area of interest*

Select Area of Interest

Research Focus

How did you hear about us*

Select a source

Leave us a message

Submitarrowarrow

Schedule a Meeting

Let us know which event you're attending and we'd be happy to connect with you.

First Name*

Last Name*

Organization*

Email*

Country/Region*

Select Country/Region

State/Province*

City

Area of interest*

Select Area of Interest

Research Focus

How did you hear about us*

Select a source

Leave us a message

Submitarrowarrow

Download

First Name*

Last Name*

Organization*

Email*

Country/Region*

Select Country/Region

State/Province*

City

Research Focus

Submitarrowarrow

Download

First Name*

Last Name*

Organization*

Email*

Country/Region*

Select Country/Region

State/Province*

City

Research Focus

Submitarrowarrow

Watch On-Demand Webinar

First Name*

Last Name*

Organization*

Email*

Country/Region

Select Country/Region

State/Province*

City

Research Focus

Submitarrowarrow

Newsletter Signup

First Name*

Last Name*

Organization*

Email*

Country/Region*

Select Country/Region

Area of interest*

Select Area of Interest

Research Focus

Submitarrowarrow